Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
NCT00040430 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of breast cancer.
Conditions
Interventions
- DRUG
-
111In-DAC
- PROCEDURE
-
Diagnostic
Sponsors & Collaborators
-
Copharos
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
NCT00208871 ·Status: COMPLETED ·Phase: NA
-
Liquid Biopsies and Imaging in Breast Cancer
NCT04223492 ·Status: COMPLETED ·Phase: NA
-
Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope
NCT00314405 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer
NCT02575612 ·Status: COMPLETED ·Phase: NA
-
Monitoring and Predicting Chemotherapy Response Using DOSI
NCT01217385 ·Status: COMPLETED ·Phase: NA
-
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
NCT05754749 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
NCT03321045 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
NCT01894451 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
NCT00003654 ·Status: TERMINATED ·Phase: NA
-
Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer Diagnosis
NCT00499980 ·Status: COMPLETED
-
Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy
NCT00535184 ·Status: COMPLETED
-
Detection of Breast Lesions by Automatic Breast US
NCT03047122 ·Status: UNKNOWN
-
DTi Diffusion Findings in Breast MRI Screening and Diagnostic
NCT03158441 ·Status: WITHDRAWN
-
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
NCT01360177 ·Status: WITHDRAWN ·Phase: NA
-
Computer-Aided Breast Cancer Detection in Women Undergoing Screening Mammography
NCT00450359 ·Status: COMPLETED ·Phase: NA
-
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 ·Status: COMPLETED
-
MRI Characterization of Mammographically Detected DCIS
NCT03495011 ·Status: ACTIVE_NOT_RECRUITING
-
In Vivo Smart Biopsy Device Protocol In Radiology
NCT03914911 ·Status: UNKNOWN ·Phase: NA
-
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
NCT03897270 ·Status: RECRUITING ·Phase: NA
-
Simulated Screening Study for Breast Imaging
NCT01807754 ·Status: COMPLETED
-
Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
NCT01502592 ·Status: COMPLETED ·Phase: PHASE1
-
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
NCT01837563 ·Status: TERMINATED
-
Digital Mammography: Computer-Aided Breast Cancer Diagnosis
NCT00732433 ·Status: COMPLETED ·Phase: NA
-
Evaluation the Diagnostic Ability of the Cancer Detection Technology (CDT) to Detect Breast Cancer Among Women Population Over Age 40
NCT01043055 ·Status: UNKNOWN
-
MRI to Detect Breast Tumors in Women
NCT00003302 ·Status: COMPLETED ·Phase: NA